Status:
UNKNOWN
Evaluation of High Velocity Nasal Insufflation in Management of Respiratory Failure in Patients With Overlap Syndrome
Lead Sponsor:
Assiut University
Conditions:
Overlap Syndrome
Obesity Hypoventilation Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
High velocity nasal insufflation (HVNI), a form of HFNC that utilizes a small bore nasal cannula to generate higher velocities of gas delivery than HFNC which uses large bore cannula, has the ability ...
Detailed Description
Overlap syndrome (OVS) is the concurrence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), and is associated with poor outcomes. COPD and obstructive sleep apnoea (O...
Eligibility Criteria
Inclusion
- Patients with respiratory failure in obesity hypoventilation syndrome and overlap syndrome, requiring ICU admission and fulfill criteria of NIMV supplementation (GOLD criteria 2021)
- patients with obesity hypoventilation syndrome and overlap syndrome diagnosed by polysomnogram or through STOP BANG Questionnaire or EPWORTH Sleepness Scale.
Exclusion
- Patients less than 18 years old
- Patients with hemodynamic instability
- Patients with central causes of hypercapnic respiratory failure
- Patients with disturbed conscious level
- Patients who refuse to participate in the study
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05190458
Start Date
March 1 2023
End Date
June 1 2024
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Respiratory ICU in Assiut University Hospitals
Asyut, Egypt, 71515